Red Queen Therapeutics is a biotechnology company.
Red Queen Therapeutics has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Red Queen Therapeutics's investors include Apple Tree Partners.
Red Queen Therapeutics is headquartered in Cambridge, United States.
Red Queen Therapeutics is a biotechnology company.
Red Queen Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Red Queen Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/red-queen-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Red Queen Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/red-queen-therapeutics
{{cite web |title=Red Queen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/red-queen-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated